|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$9,381
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
The Center for Therapeutic Targeting of EWS-oncoproteins
|
1U54CA231637-01
|
$12,500,000
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
|
1U54CA232568-01
|
$12,197,183
|
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Targeting SS18-SSX biology in synovial sarcomagenesis
|
1U54CA231652-01
|
$11,520,799
|
|
JONES, KEVIN
|
UNIVERSITY OF UTAH
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-38
|
$6,063,271
|
$242,531
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The Center for Synovial Sarcoma Biology and Therapeutics
|
1U54CA231638-01
|
$5,251,652
|
|
KADOCH, CIGALL
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$51,297
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016042-42
|
$4,295,192
|
$128,856
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
|
1U01CA232491-01
|
$4,129,375
|
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
|
1U01CA232486-01
|
$3,950,741
|
|
FRY, TERRY
|
UNIVERSITY OF COLORADO DENVER
|
|
Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers
|
1U01CA232488-01
|
$3,370,657
|
|
WANG, RUONING
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Stanford Cancer Institute
|
5P30CA124435-10
|
$3,338,488
|
$100,155
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
|
1U01CA232563-01
|
$2,931,750
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
ASPirin in Reducing Events in the Elderly
|
3U01AG029824-07S2
|
$2,820,000
|
|
MURRAY, ANNE
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$26,456
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-03
|
$2,373,000
|
$189,840
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Cancer Center Support Grant
|
2P30CA012197-42
|
$2,325,000
|
$23,250
|
PASCHE, BORIS
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$22,850
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-24
|
$2,258,441
|
$22,584
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
|
1U01CA232490-01
|
$2,200,000
|
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
|
1R35CA220497-01A1
|
$1,047,525
|
|
JANNE, PASI
|
DANA-FARBER CANCER INST
|
|
Risk Factors for Breast Cancer in Younger Nurses
|
5R01CA050385-28
|
$1,041,084
|
$52,054
|
WILLETT, WALTER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
|
1R35CA232097-01
|
$1,040,850
|
|
CHAN, TIMOTHY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Systemic regulation of metastasis
|
1R35CA232093-01
|
$1,017,000
|
|
LYDEN, DAVID
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Epigenetic Circuits in B-Cell Lymphomas
|
1R35CA220499-01A1
|
$1,017,000
|
|
MELNICK, ARI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
|
1R35CA220508-01A1
|
$1,012,275
|
|
IACOBUZIO-DONAHUE, CHRISTINE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unraveling the Complexities of Risk and Mechanism in Cancer
|
1R35CA220523-01A1
|
$978,294
|
|
QUACKENBUSH, JOHN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
The power of extracellular vesicles in glioblastoma
|
1R35CA232103-01
|
$935,071
|
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Exploring Precision Oncology: From Gene Fusions to lncRNAs
|
1R35CA231996-01
|
$928,651
|
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Mesocale And Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
|
1R35CA220430-01A1
|
$921,471
|
|
TAINER, JOHN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Targeting undruggable RAS for cancer treatment
|
1R35CA232113-01
|
$909,182
|
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Chemical Proteomic Platforms for Radically Expanding Cancer Druggability
|
1R35CA231991-01
|
$876,967
|
|
CRAVATT, BENJAMIN
|
SCRIPPS RESEARCH INSTITUTE
|
|
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
|
1R35CA220526-01A1
|
$873,370
|
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
|
1R35CA220502-01A1
|
$867,671
|
|
BHATIA, SMITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Federated Galaxy for user-friendly large-scale cancer genomics research
|
1U24CA231877-01
|
$823,902
|
|
GOECKS, JEREMY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
High-speed panoramic 3D photoacoustic computed tomography of the breast
|
1R35CA220436-01A1
|
$802,428
|
|
WANG, LIHONG
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Mechanisms of Regulated Cell Death
|
1R35CA231620-01
|
$792,792
|
|
GREEN, DOUGLAS
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
|
1R01CA223823-01A1
|
$784,837
|
|
DUCKETT, DEREK
|
SCRIPPS FLORIDA
|
|
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
|
1R01CA225005-01A1
|
$771,034
|
|
FRIEDMAN, DEBRA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
|
1U01CA232161-01
|
$747,298
|
|
VIDAL, MARC
|
DANA-FARBER CANCER INST
|
|
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
|
1R01CA207446-01A1
|
$736,373
|
$736,373
|
REDD, WILLIAM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
|
1R01CA219670-01A1
|
$726,766
|
|
EL-BARDEESY, NABEEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
|
1R01CA224918-01A1
|
$722,281
|
|
DIEFENBACH, MICHAEL
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
|
2R01CA166379-06
|
$722,235
|
|
FISCHER, GREGORY
|
WORCESTER POLYTECHNIC INSTITUTE
|
|
Attacking stress tolerance in cancer
|
1R35CA220512-01A1
|
$709,531
|
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
|
1R35CA231998-01
|
$693,376
|
|
GRANDIS, JENNIFER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Systematic Light Exposure for Fatigue in Stem Cell Transplant Survivors
|
5R01CA193523-02
|
$690,812
|
$690,812
|
REDD, WILLIAM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Sleep Disorders for this search: $11,459,180
|